Horn advised Scopio Labs on the deal. Scopio Labs completed the collaboration agreement with Siemens Healthineers to Distribute Full-Field Digital Cell Morphology Technology. Scopio Labs provides digital...
Scopio Labs’ Collaboration Agreement with Siemens Healthineers
VBL Therapeutics’ Merger with Notable Labs
Horn & Co. represented VBL Therapeutics on the deal. VBL Therapeutics executed the merger with Notable Labs. The merger aims to create Nasdaq-listed, clinical-stage therapeutic platform company developing new...
Purple Biotech’s Acquisition of Immunorizon
Horn&Co. advised Immunorizon on the deal. Purple Biotech executed the acquisition of Immunorizon in consideration for up to $100 million. Purple Biotech Ltd. is a clinical-stage company...
INX Digital Company’s Joint Venture with SICPA
Horn & Co. advised The INX Digital Company on the deal. The INX Digital Company, Inc. executed a joint venture with SICPA SA in the field...
Kamari Pharma’s $8 Million Raising Fund
Horn & Co. advised Kamari Pharma on the deal. Kamari Pharma executed a joint venture agreement raising $8 million. Kamari Pharma is a biopharmaceutical company that is developing...
Diagnostic Robotics’ Series B Fundraising
Horn & Co. represented Diagnostic Robotics in the deal, Amit, Pollak, Matalon & Co. advised StageOne, Migdal Insurance, Clal Insurance and Bank Hapoalim on the transaction....
Prisma Photonics’ $20 Million Capital Raising
Horn & Co. advised Prisma Photonics on the deal. ERM advised Future Energy Ventures on the transaction. Prisma Photonics Ltd. executed a $20 million raise from Insight...
INX Digital Company’s Reverse Takeover
Horn & Co. advised INX Digital Company on the deal. INX Digital Company, Inc. closed its reverse takeover transaction. INX Digital Company Inc. which include regulated trading platforms for digital...
Emergence Therapeutics’ Series A Financing Round
ARQIS has advised biotech company Emergence Therapeutics AG on the deal, while Horn&Co. advised Pontifax Ventures 6. J&A advised Bpifrance. Weitnauer advised NRW.BANK. The round was...
Zebra Medical Vision’s $200 Million Merger with Nanox Vision
Horn & Co. advised Zebra Medical Vision on the deal. APM&Co represented NANO-X IMAGING Ltd on the deal. Zebra Medical Vision Ltd. executed a $200 million merger...
Biosight’s Merger with Advaxis
Horn & Co. advised Biosight Ltd. in the transaction. Biosight Ltd. signed a merger agreement with Advaxis, Inc, a clinical-stage biotechnology company. BioSight is a pharmaceutical development...
Theator’s Collaboration Agreement with Mayo Clinic
Horn & Co. advised Theator in the deal. Theator signed a collaboration agreement with Mayo Clinic. The collaboration enables Theator to broaden the capabilities of its surgical intelligence platform...